Don't miss your chance to win big on biotech. [Wealthy Retirement]( SPONSORED [Is your name on one of these lists?]( [Bryan List]( [If so, the government is holding a check for you.]( 940 MILLION of these checks are waiting to be claimed. [Follow these three steps.]( Editor's Note: This week, we're featuring a sector that Chief Income Strategist Marc Lichtenfeld calls "the most important in the market" - the biotech sector. Marc is no stranger to biotech investing... In fact, recently, he led his readers to a 2,381% partial options win on AbbVie (NYSE: ABBV). [Click here]( to learn what he's got his sights set on next. Read on to learn what makes this sector so special. - Mable Buchanan, Managing Editor [BIOTECH STOCKS]( Marc's 5 Criteria for a Strong Biotech Stock Rachel Gearhart, Associate Franchise Publisher, The Oxford Club [State of the Market Thumbnail]( Many of you know Chief Income Strategist Marc Lichtenfeld as the "income guy" because of his work with The Oxford Income Letter... But he's as passionate about biotech investing as he is about dividends. In fact, he's been tracking the sector for several decades now and has spoken about biotech opportunities at events all over the world. One of these events just ended this week: the 39th Annual J.P. Morgan Health Care Conference, which took place virtually from January 11 through January 14. This year's conference took on subjects like healthcare disparities, the rise of outpatient surgery centers and even the development of germ-killing robots. In honor of this event, which hosts the best and brightest upcoming companies and is often rife with exciting announcements, we've decided to revisit one of Marc's most popular [State of the Market]( videos... SPONSORED [Shocking Discovery Turns Ones and Zeros Into Big Bucks!]( [Abstact Eye]( Computer engineers have found a way to transform lines of code into a moneymaking technology we call "Nexus." Kiplinger's says that this discovery "could be as world-changing as the internet." And the World Economic Forum predicts that 10% of the global GDP - that's $14.7 TRILLION - could be stored on this tech by 2027. [Here's how it works...]( It's important - no matter how exciting a biotech company's technology may be or how compelling its story may be - to ensure that its business is healthy as well. So in this short video, Marc outlines the five specific qualifications he looks for before recommending a biotech company. [Click here to watch it now]( Then, check out his latest research on how biotech investors could earn up to 3,000% in the next year thanks to special events he calls "Lightning Strikes." He wants to make sure his research finds as many people as possible... Because last time - when he showed readers the chance to earn 2,381% in 10 months - fewer than 1% of them followed his lead. By not listening, readers missed out on life-changing gains. So don't miss your chance... [Click here to watch Marc's video presentation.]( [>Here are the details.<]( Good investing, Rachel [Leave a Comment]( MORE FROM WEALTHY RETIREMENT [Your Biotech Investing Checklist]( [Making the Most of April's Rare Buying Opportunity]( [Start Spreadin' the News - Is This 6% Yield Leaving Today?]( [Facebook](
[Facebook](
[Twitter](
[Twitter](
[Email Share](mailto:?subject=A%20great%20piece%20from%20Wealthy%20Retirement...&body=From%20Wealthy%20Retirement:%0D%0A%0D%0ADon't%20miss%20your%20chance%20to%20win%20big%20on%20biotech.%0D%0A%0D
[Email Share](mailto:?subject=A%20great%20piece%20from%20Wealthy%20Retirement...&body=From%20Wealthy%20Retirement:%0D%0A%0D%0ADon't%20miss%20your%20chance%20to%20win%20big%20on%20biotech.%0D%0A%0D SPONSORED [Bill O'Reilly Was Left SPEECHLESS by This Letter (Holy Cow!!)]( [Bill O'Reilley]( It's not often that a TV legend like Bill O'Reilly is left speechless LIVE on the air. It turns out one of his listeners wrote to him, "Bill, in less than three weeks I have made $5,867 (up 25%)... holy cow!" See the special O'Reilly broadcast that showed this man the proven path to financial success (and how you can achieve it too)... [CLICK HERE FOR THE SPECIAL O'REILLY BROADCAST!]( [The Oxford Club]( You are receiving this email because you subscribed to Wealthy Retirement.
Wealthy Retirement is published by The Oxford Club.
Questions? Check out our [FAQs](. Trying to reach us? [Contact us here.]( Please do not reply to this email as it goes to an unmonitored inbox. [Privacy Policy]( | [Whitelist Wealthy Retirement]( | [Unsubscribe]( © 2021 The Oxford Club, LLC All Rights Reserved
The Oxford Club | [105 West Monument Street](#) | [Baltimore, MD 21201](#)
North America: [1.800.589.3430](#) | International: [+1.443.353.4334](#) | Fax: [1.410.329.1923](#)
[Oxfordclub.com]( The Oxford Club is a financial publisher that does not offer any personal financial advice or advocate the purchase or sale of any security or investment for any specific individual. Members should be aware that although our track record is highly rated by an independent analysis and has been legally reviewed, investment markets have inherent risks and there can be no guarantee of future profits. The stated returns may also include option trades. We expressly forbid our writers from having a financial interest in their own securities recommendations to readers. All of our employees and agents must wait 24 hours after online publication or 72 hours after the mailing of printed-only publications prior to following an initial recommendation. Any investments recommended by The Oxford Club should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The Oxford Club, 105 W. Monument Street, Baltimore MD 21201.